A story in the Dec. 12, 2000, issue of BioWorld Today should have said shareholders of BioChem Pharma Inc. will get $37 worth of Shire Pharmaceuticals Group plc shares per BioChem share, provided the average close price of a Shire American Depository Share during the last 15 trading days - ending on the third trading day prior to closing of their merger - is between $47.20 and $70.80. The companies provided the erroneous numbers in their initial news release.

Editor's Note: The correction will be made Tuesday in BioWorld Online.